Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionFusion protein consisting of a human mAb with specificity for the dendritic cell receptor linked to cancer/testis antigen 1B (CTAG1B; NY-ESO-1)
Molecular Target Cancer/testis antigen 1B (NY-ESO-1) (CTAG1B)
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today